A ‘living GLP-1 drug’ could revolutionize diabetes treatment
The engineered E. coli responds to elevated glucose levels by releasing GLP-1. (Science Photo Library/Canva) – By Mike McRae 2026 Aug 19 – Bacteria engineered to sense and reduce glucose levels could be the future of type 2 diabetes treatments, following pre-clinical trials on …